You are viewing: UK Latent TB Testing Market analysis
Part of: Latent TB Testing Market (Global)

The UK Latent TB Testing Market was valued at $25.37 Million in 2024 and projected to reach to $38.34 Million by 2029, representing a compound annual growth rate of 8.6%. The UK latent TB testing market is positioned for sustained growth through 2029, driven by enhanced public health initiatives and improved access to diagnostic services across the National Health Service.

UK Latent TB Testing Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

UK Latent TB Testing Market Trends and Insights

  • This expansion reflects the UK's strengthened commitment to TB elimination and increased screening initiatives across healthcare settings.
  • The UK market is driven by rising awareness of latent tuberculosis infection (LTBI) among high-risk populations, including healthcare workers, immigrants, and immunocompromised individuals. The UK's healthcare infrastructure and NHS investment in TB prevention programmes are key catalysts for market expansion.
  • Between 2024 and 2029, the UK is expected to see accelerated adoption of interferon-gamma release assays (IGRAs) and tuberculin skin tests (TSTs) as diagnostic standards.
  • The UK market's 8.6% compound annual growth rate significantly outpaces global trends, positioning the country as a high-growth region within Europe's latent TB testing landscape..

Key Market Statistics

  • CAGR (2024-2029) 8.6% CAGR
  • Market Size, 2024 ~USD 25.37 Million
  • Forecast, 2029 ~USD 38.34 Million
  • Country UK

UK Latent TB Testing Market Overview

Market Valuation Growth :

The UK latent TB testing market is valued at £25.37 million in 2024, with a projected expansion to £38.34 million by 2029, representing a robust 8.6% CAGR significantly outpacing the global average of 5.8%.

NHS TB Elimination Strategy :

The UK's strengthened commitment to TB elimination through the NHS has catalysed increased screening initiatives across primary care, secondary care, and occupational health settings, driving market expansion.

High-Risk Population Screening :

Rising awareness of latent tuberculosis infection (LTBI) among high-risk populations including migrants, healthcare workers, and immunocompromised individuals is accelerating demand for diagnostic testing across UK healthcare facilities.

Regulatory Support & Guidelines :

Updated NICE guidelines and Public Health England recommendations for LTBI screening in specific populations have strengthened the clinical case for expanded testing programmes in UK healthcare settings.

UK Latent TB Testing Market Dynamics

  • Increasing prevalence of TB in urban centres and growing recognition of LTBI's role in TB transmission are prompting healthcare providers to expand screening programmes.
  • The market will benefit from technological advancements in testing methodologies and integration of latent TB diagnostics into routine occupational health protocols.
  • Investment in TB elimination strategies and targeted screening of vulnerable populations will continue to support market expansion, with particular growth expected in interferon-gamma release assays (IGRAs) and molecular testing platforms..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • The UK latent TB testing market is valued at £25.37 million in 2024 and will reach £38.34 million by 2029, representing 51% growth over five years.
    • The UK's 8.6% CAGR substantially exceeds the global average of 5.8%, indicating accelerated market momentum in the region.
    • NHS-led TB prevention programmes and heightened screening in the UK are driving adoption of advanced diagnostic technologies.
    • The UK market benefits from strong regulatory frameworks and healthcare infrastructure supporting widespread latent TB testing implementation.

    Latent TB Testing Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment HOUSEHOLD CONTACTS WITH PULMONARY TB (Application)
    Forecast Period 2024-2029
    Growth Rate CAGR of 5.8% from 2024 to 2029
    Largest Segment IGRA (Test Type)
    Market Size Base Year (Billions) ~USD 0.58 (2024)
    Revenue Forecast (Billions) ~USD 0.77 (2029)
    Segments Covered Test Type, Application, End User

    UK Latent TB Testing Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Test Type

    • Igra
    • Tst

    By Application

    • Household Contacts With Pulmonary Tb
    • Other Applications
    • People Living With Hiv

    By End User

    • Academic & Research Institutes
    • Diagnostic Laboratories
    • Hospitals & Clinics
    • Other End Users

    UK: LATENT TB TESTING MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    ACADEMIC & RESEARCH INSTITUTES1.762.062.142.252.382.532.722.936.4
    DIAGNOSTIC LABORATORIES15.6418.7119.8521.2322.9324.9427.3130.058.6
    HOSPITALS & CLINICS4.675.55.746.056.436.897.438.057
    OTHER END USERS0.921.071.11.151.211.281.371.475.9
    TOTAL22.9927.3428.8430.6732.9435.6438.8342.58.1

    Target Audience

    • NHS Trust Procurement Teams : Need UK market data to evaluate diagnostic suppliers, benchmark pricing, and justify investment in latent TB testing infrastructure aligned with national TB elimination targets.
    • In Vitro Diagnostics Manufacturers : Require UK-specific market intelligence to assess commercial viability of IGRA and molecular testing platforms, identify distribution partnerships, and develop UK-tailored product strategies.
    • Occupational Health Providers : Need insights into UK regulatory requirements and screening protocols for healthcare worker TB testing to enhance service offerings and ensure compliance with occupational health standards.
    • Public Health England & Local Authority Officials : Require market data to support TB elimination programme planning, resource allocation, and evaluation of screening effectiveness across UK regions and vulnerable populations.
    • Private Healthcare & Clinic Operators : Need UK market forecasts and demand drivers to identify opportunities for latent TB testing service expansion, particularly in travel medicine, immigration health, and occupational health sectors.

    Reasons to Buy this Report

    • UK-Specific Market Sizing : Access precise valuation data for the UK latent TB testing market with country-specific forecasts through 2029, enabling accurate budget allocation and investment planning for UK healthcare operations.
    • NHS Strategy Alignment : Understand how NHS TB elimination initiatives and NICE guidelines are reshaping the UK testing landscape, allowing healthcare providers to align procurement and service development with national priorities.
    • Competitive Landscape Intelligence : Gain insights into UK-specific market dynamics, key diagnostic providers, and adoption rates of testing methodologies to inform competitive positioning and market entry strategies.
    • High-Risk Population Segmentation : Identify UK-specific high-risk populations driving demand for LTBI testing, including migrant communities, healthcare workers, and immunocompromised groups, to tailor marketing and service offerings.
    • Growth Opportunity Assessment : Leverage UK market data showing 8.6% CAGR to identify expansion opportunities in underserved regions and healthcare settings, supporting strategic business development and partnership initiatives.

    Frequently asked questions

    What is the current size of the UK latent TB testing market?

    The UK latent TB testing market was valued at £25.37 million in 2024 and is projected to grow to £38.34 million by 2029.

    What is the growth rate of the UK latent TB testing market?

    The UK latent TB testing market is growing at a compound annual growth rate (CAGR) of 8.6% from 2024 to 2029.

    Which diagnostic technologies dominate the UK latent TB testing market?

    Interferon-gamma release assays (IGRAs) and tuberculin skin tests (TSTs) are the primary diagnostic technologies used in the UK market.

    What factors are driving growth in the UK latent TB testing market?

    Key drivers include NHS TB prevention initiatives, increased screening of high-risk populations, healthcare worker screening programmes, and rising awareness of latent TB infection.

    How does the UK market compare to global latent TB testing trends?

    The UK's 8.6% CAGR significantly outpaces the global average of 5.8%, making it one of Europe's fastest-growing latent TB testing markets.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size for the latent TB testing market. Exhaustive secondary research was done to collect information on the latent TB testing industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the latent TB testing market.

    The four steps involved in estimating the market size are

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.

    The following is a breakdown of the primary respondents:

    Note 1: Others include sales managers, marketing managers, and product managers.

    Note 2: Companies are classified into tiers based on their total revenues. As of 2022/2023, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.

    To know about the assumptions considered for the study, download the pdf brochure

    COMPANY NAME DESIGNATION
    QIAGEN General Manager
    Revvity Area Sales Manager

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the latent TB testing market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    • The key players in the industry have been identified through extensive secondary research
    • The revenues generated by leading players operating in the latent TB testing market have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    The research methodology used to estimate the market size includes the following:

    Data Triangulation

    After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Latent tuberculosis testing refers to diagnosing the infection by detecting an immune response to Mycobacterium tuberculosis antigens using either the tuberculin skin test (TST) or interferon-gamma release assays (IGRAs). These tests help identify dormant tuberculosis infections in individuals without active symptoms.

    Stakeholders

    • Senior Management
    • End User
    • Finance/Procurement Department  
    • R&D Department

    Report Objectives

    • To define, describe, segment, and forecast the global latent TB testing market, by test type, application, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall latent TB testing market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Middle East & Africa, and Latin America
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
    • To benchmark players within the market using the proprietary Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product excellence

     

    Get the Full Latent TB Testing Market Report

    Full forecast, segment splits, and company analysis for all Latent TB Testing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status